ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 67 • 2015 ACR/ARHP Annual Meeting

    Higher Levels of Pro-Inflammatory and Lower Levels of Anti-Inflammatory Cytokines Are  Present in Fibromyalgia Patients

    Robert S. Katz1, Hannah Leavitt2 and Daniel Pickrell2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates, Chicago, IL

    Background/Purpose: Abnormalities in the central processing of pain may play a role in fibromyalgia and cytokines could be targets for new therapies. We measured cytokine levels…
  • Abstract Number: 68 • 2015 ACR/ARHP Annual Meeting

    The Stroop Word-Naming Test in Fibromyalgia Patients

    Robert S. Katz1, Alexandra Katz Small1,2 and Kelli Davis3, 1Rush University Medical Center, Chicago, IL, 2University of Illinois College of Medicine, Chicago, IL, 3Rheumatology Associates S.C., Chicago, IL

    Background/Purpose:   The Stroop Word-Naming Test has demonstrated decreased word-naming speed in many patients with fibromyalgia who experience the symptoms of fibrofog.  The slower processing…
  • Abstract Number: 69 • 2015 ACR/ARHP Annual Meeting

    Fibrofog in Mild and Severe Variants of Fibromyalgia

    Robert S. Katz and Frank Leavitt, Rush University Medical Center, Chicago, IL

    Background/Purpose: : A triad of symptoms defines cognitive dysfunction in fibromyalgia known as fibrofog. The set of primary signs are short-term memory loss, a general…
  • Abstract Number: 70 • 2015 ACR/ARHP Annual Meeting

    Data from Brazilian Fibromyalgia Patients Registry (EPIFIBRO) in 2014

    Jose Eduardo Martinez1,2, Marcelo C. Rezende3,4, Eduardo Paiva4,5, Daniel Pollak4,6, Milton Helfenstein Jr4,7, Jose Roberto Provenza4,8, Aline Ranzolin4,9, Roberto E Heymann4,10, Eduardo L. Ribeiro4,11, Marcos Renato Assis4,12 and Eduardo J. R. Souza4,13, 1Sociedade Brasileira de Reumatologia, Sorocaba, Brazil, 2Medicine, Pontifical Catholic University of Sao Paulo, Sorocaba, Brazil, 3Santa Casa de Campo Grande, Campo Grande, Brazil, 4Sociedade Brasileira de Reumatologia, São Paulo, Brazil, 5Rheumatology, Universidade Federal do Parana, Curitiba, Brazil, 6Rheumathology, Universidade Federal de São Paulo, São Paulo, Brazil, 7RUA JOAO DE LACERDA SOARES, 90, Unifesp, Sao Paulo, Brazil, 8Rheumatology, Pontifícia Universidade Católica de Campinas, Campinas, Brazil, 9Hospital das Clínicas - Universidade Federal de Pernambuco, Recife, Brazil, 10Universidade Federal de São Paulo, São Paulo, Brazil, 11Instituto de Previdência dos Servidores do Estado de Minas Gerais, Belo Horizonte, Brazil, 12Faculdade de Medicina de Marilia, Marilia, Brazil, 13Santa Casa de Belo Horizonte, Belo Horizonte, Brazil

    Background/Purpose: –The Brazilian registry on fibromyalgia syndrome (EPIFIBRO) included 810 patients who satisfied the American College of Rheumatology Classification Criteria for Fibromyalgia (ACR1990) at the…
  • Abstract Number: 71 • 2015 ACR/ARHP Annual Meeting

    Fibromyalgia Dysautonomia and Distress. Correlation Between the Newly Developed Composite Autonomic Symptoms (COMPASS-31) Questionnaire and the Fibromyalgia  Polysymptomatic Distress Scale

    Laura-Aline Martinez-Martinez1, Maya Chacón Pérez2, Paola Reyes-Loyola3 and Manuel Martínez-Lavín3, 1National Institute of Cardiology. Mexico, Mexico City, TX, Mexico, 2National Institute of Cardiology, Mexico City, Mexico, 3National Institute of Cardiology. Mexico, Mexico City, Mexico

    Background/Purpose: A consistent line of investigation suggests that dysautonomia may explain the multisystem fibromyalgia features, and that fibromyalgia is a sympathetically maintained neuropathic pain syndrome.…
  • Abstract Number: 72 • 2015 ACR/ARHP Annual Meeting

    Performance of the New Survey Criteria for Fibromyalgia Under Conditions of  Low and High Symptom Activity

    Robert S. Katz and Frank Leavitt, Rush University Medical Center, Chicago, IL

    Background/Purpose: In 2010, new criteria for fibromyalgia were proposed. In 2011, the questionnaire was adjusted so that patients provided the necessary information to satisfy the…
  • Abstract Number: 73 • 2015 ACR/ARHP Annual Meeting

    Anti -N-Methyl-D-Aspartate Receptor Antibody Is Associated with Fibromyalgia in Patients with Systemic Lupus Erythematosus

    Jeong-Won Lee1, Dong-Jin Park2, Yi-Rang Yim1, Ji-Eun Kim1, Kyung-Eun Lee1, Lihui Wen1 and Shin-Seok Lee1, 1Chonnam National University Medical School and Hospital, Gwangju, South Korea, 2Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea

    Background/Purpose: The high concordance of systemic lupus erythematosus (SLE) with fibromyalgia (FM) suggests common underlying mechanisms related to pain and distress in both patient groups.…
  • Abstract Number: 74 • 2015 ACR/ARHP Annual Meeting

    Clinical Characteristics of Fibromyalgia in a Chronic Pain Population

    Mark Gostine1, Fred Davis1, Bradley Roberts2, Rebecca Risko2, Joseph Cappelleri3, Michael Asmus4, Andrew Clair5 and Alesia Sadosky6, 1Michigan Pain Consultants, PC, Grand Rapids, MI, 2ProCare Systems, Inc., Grand Rapids, MI, 3Biostatistics, Pfizer, Inc., Groton, CT, 4North American Medical Affairs, Pfizer, Inc., Middleton, WI, 5Pfizer Inc., New York, NY, 6Pfizer Inc,, New York, NY

    Background/Purpose: The study’s purpose was to advance the understanding and treatment of fibromyalgia (FM) for patients in a chronic pain management center.  FM is a…
  • Abstract Number: 75 • 2015 ACR/ARHP Annual Meeting

    Fibromyalgia and Positional Cervical Cord Compression Differ Only By Autonomic Nervous System Consequences: A Double-Blinded, Prospective Study

    Andrew Holman, Pacific Rheumatology Reseach, Seattle, WA

    Background/Purpose: In 1998, C Muhle and D Resnick proposed a corollary to cervical spinal stenosis caused by intermittent abutment of the cervical spinal cord from…
  • Abstract Number: 76 • 2015 ACR/ARHP Annual Meeting

    Evaluating Weather’s Effect on Fibromyalgia Patients Using the Revised Fibromyalgia Impact Questionnaire and the Brief Pain Inventory

    Daniel Kim1, Ruth Chan1, Marcal Plans2 and Kevin Hackshaw1, 1Rheumatology & Immunology, Ohio State University, Columbus, OH, 2Food Science and Technology Department, Ohio State University, Columbus, OH

    Background/Purpose: The objective of this study was to evaluate whether weather had an affect on fibromyalgia symptoms as measured by the Revised Fibromyalgia Impact Questionnaire…
  • Abstract Number: 78 • 2015 ACR/ARHP Annual Meeting

    Exploratory Analysis of Somatic Symptoms in Fibromyalgia By Multidimensional Scaling and Latent Class Analysis

    Marco Antivalle1, Michele Battellino1, Alberto Batticciotto1, MariaChiara Ditto1, Alessandra Mutti1, Valentina Varisco1, Federica Rigamonti1, Fabiola Atzeni1 and Piercarlo Sarzi-Puttini2, 1Rheumatology, L. Sacco University Hospital, Milano, Italy, 2Rheumatology Unit, L. Sacco University Hospital, Milano, Italy

    Background/Purpose: Attempts to individuate subsets of fibromyalgia patients based on the aggregation of different symptoms have so far produced conflicting results. The 2010 preliminary diagnostic…
  • Abstract Number: 79 • 2015 ACR/ARHP Annual Meeting

    Hypervigilence: Patients with Fibromyalgia Often Appear Very Sensitive to Environmental Stresses

    Robert S. Katz1, Kelli Davis2, Lauren Kwan2 and Jessica L. Polyak2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

    Background/Purpose: We inquired about hypervigilence and hypersensitivity to various environmental stresses in patients with fibromyalgia and in rheumatic disease controls. Methods: 103 fibromyalgia patients with…
  • Abstract Number: 80 • 2015 ACR/ARHP Annual Meeting

    Paresthesias in Fibromyalgia Patients

    Robert S. Katz1, Lauren Kwan2, Kelli Davis2 and Jessica L. Polyak2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

    Background/Purpose:   Paresthesias are common in patients with fibromyalgia.  We evaluated the symptoms of numbness and tingling in fibromyalgia patients and rheumatic disease controls without…
  • Abstract Number: 81 • 2015 ACR/ARHP Annual Meeting

    The Value of Routine Use of Creatine Kinase and Thyroid Stimulating Hormone Tests in Patients with Suspected Fibromyalgia: Results of a Cross-Sectional Study

    Nadine Boers1, Nathan den Broeder1, Judith van Vliet2, Ronald F. van Vollenhoven3, Nienke Lesuis1 and Alfons A. den Broeder1, 1Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 2Neurology, Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands, 3Department of Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden

    Background/Purpose: Creatine kinase (CK) and Thyroid stimulating hormone (TSH) are frequently used tests in the diagnostic work-up of fibromyalgia (FMS) to exclude thyroid disease or…
  • Abstract Number: 82 • 2015 ACR/ARHP Annual Meeting

    Cross-Sectional Analysis of Heart Rate Variability in Patients with Fibromyalgia (FM): Correlations with Baseline Clinical Measures

    Adam Dziuba1, Nancy A. Lockhart2, Howard Schubiner3, Daniel J. Clauw4, David A. Williams5 and Mark A. Lumley2, 1Medical School, University of Michigan, Ann Arbor, MI, 2Psychology, Wayne State University, Detroit, MI, 3Wayne State University, Detroit, MI, 4Anesthesiology, University of Michigan, Ann Arbor, MI, 5Anesthseiology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Autonomic nervous system (ANS) dysfunction is thought to play a role in the pathophysiology and symptoms of FM. Evaluation of the ANS may be…
  • « Previous Page
  • 1
  • …
  • 1874
  • 1875
  • 1876
  • 1877
  • 1878
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology